Kallyope Receives $21 Million in Series B Financing to Target the Gut-Brain Axis

December 5, 2018


Kallyope Inc., a leading biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, today announced a $21 million expansion of its previously announced Series B financing, bringing the Series B round total to $87 million. The company will use the additional funds to further advance its portfolio of programs targeting the gut-brain axis. Kallyope has now raised $131 million in equity capital since inception.
The expanded financing was led by Bill Gates. All previous Kallyope investors participated, including Lux Capital, The Column Group, Polaris Partners, Illumina Ventures, Alexandria Venture Investments, Euclidean Capital, and Two Sigma Ventures.

“We are grateful for the support of Mr. Gates and the renewed support of our current investors, who all share Kallyope’s vision that a comprehensive understanding of gut-brain circuits will allow us to target diseases of high unmet need in a fundamentally new way,” said Nancy Thornberry, CEO of Kallyope. “This additional infusion of capital will enable us to maximize the value of our platform and more rapidly advance our programs.”

The gut-brain axis, the bi-directional communication system between the gut and the brain, modulates key aspects of physiology and behavior and is linked to a number of diseases. Kallyope has developed a platform that enables a systematic approach to targeting gut-brain circuits with small molecules and has initiated multiple programs spanning metabolic, central nervous system, and gastrointestinal disorders. In addition to its internal small molecule programs, Kallyope recently initiated a collaboration with Novo Nordisk A/S focusing on the discovery of peptide therapeutics for the treatment of obesity and diabetes.

Tags:

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.